These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 8031607

  • 1. [The expression of HLA, Epstein-Barr virus nuclear antigen and the infiltration of T lymphocyte subsets in nasopharyngeal biopsy tissues].
    Chen X, Cai Y, Sun N.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(1):6-9. PubMed ID: 8031607
    [Abstract] [Full Text] [Related]

  • 2. Constitutive expression of HLA class II antigens on EBV positive malignant cells from nasopharyngeal carcinoma: possible involvement in T cell infiltration.
    Busson P, Braham K, Clausse B, Tursz T.
    Cancer Detect Prev; 1988; 12(1-6):363-8. PubMed ID: 2846171
    [Abstract] [Full Text] [Related]

  • 3. [Investigation of EB virus DNA BamHI W fragment, EBNA-2 types and EBNA expression in benign and malignant nasopharyngeal biopsies].
    Chen XY, Ning S, Arrand JR.
    Zhonghua Bing Li Xue Za Zhi; 1994 Aug; 23(4):200-3. PubMed ID: 7805145
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line.
    Zhang Q, Brooks L, Busson P, Wang F, Charron D, Kieff E, Rickinson AB, Tursz T.
    Eur J Immunol; 1994 Jun; 24(6):1467-70. PubMed ID: 8206105
    [Abstract] [Full Text] [Related]

  • 5. [The value of polymerase chain reaction on Epstein-Barr virus subtypes in the differentiation of benign and malignant nasopharyngeal biopsies].
    Sun N, Chen X.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995 Jun; 30(4):213-5. PubMed ID: 8745459
    [Abstract] [Full Text] [Related]

  • 6. Attachment of antinuclear antibodies to nasopharyngeal carcinoma or other cells during preparation of biopsy imprints.
    Henle W, Henle G, Lanier AP, Bornkamm GW.
    J Natl Cancer Inst; 1986 Jun; 76(6):1041-6. PubMed ID: 3012176
    [Abstract] [Full Text] [Related]

  • 7. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP.
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [Abstract] [Full Text] [Related]

  • 8. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y.
    Chin Med J (Engl); 2009 May 20; 122(10):1173-8. PubMed ID: 19493466
    [Abstract] [Full Text] [Related]

  • 9. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y, Sheen TS, Lu J, Huang YT, Chen JY, Yang CS, Tsai CH.
    Lab Invest; 1998 Jun 20; 78(6):715-26. PubMed ID: 9645762
    [Abstract] [Full Text] [Related]

  • 10. HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma.
    Karanikiotis C, Daniilidis M, Karyotis N, Bakogiannis C, Economopoulos T, Murray S, Papamichael D, Samantas E, Nikolaou A, Skoura L, Tselis N, Zamboglou N, Fountzilas G.
    Strahlenther Onkol; 2008 Jun 20; 184(6):325-31. PubMed ID: 18535809
    [Abstract] [Full Text] [Related]

  • 11. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D.
    Chow KC, Ma J, Lin LS, Chi KH, Yen SH, Liu SM, Liu WT, Chen WK, Chang TH, Chen KY.
    Cancer Epidemiol Biomarkers Prev; 1997 May 20; 6(5):363-8. PubMed ID: 9149897
    [Abstract] [Full Text] [Related]

  • 12. Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo.
    Sheu LF, Chen A, Meng CL, Ho KC, Lee WH, Leu FJ, Chao CF.
    J Pathol; 1996 Nov 20; 180(3):243-8. PubMed ID: 8958799
    [Abstract] [Full Text] [Related]

  • 13. Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma.
    Hildesheim A, West S, DeVeyra E, De Guzman MF, Jurado A, Jones C, Imai J, Hinuma Y.
    Cancer Res; 1992 Jun 01; 52(11):3048-51. PubMed ID: 1317256
    [Abstract] [Full Text] [Related]

  • 14. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
    You S, Yao K, Cao Y.
    Zhonghua Zhong Liu Za Zhi; 1996 Jan 01; 18(1):23-6. PubMed ID: 8732106
    [Abstract] [Full Text] [Related]

  • 15. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT, Lin CR, Tan GK, Chen W, Dee AN, Chan WY.
    Am J Pathol; 1997 May 01; 150(5):1745-56. PubMed ID: 9137098
    [Abstract] [Full Text] [Related]

  • 16. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.
    Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282
    [Abstract] [Full Text] [Related]

  • 17. Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells.
    Huang YT, Sheen TS, Chen CL, Lu J, Chang Y, Chen JY, Tsai CH.
    Cancer Res; 1999 Apr 01; 59(7):1599-605. PubMed ID: 10197635
    [Abstract] [Full Text] [Related]

  • 18. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM.
    J Med Virol; 2007 Nov 01; 79(11):1710-21. PubMed ID: 17854043
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids.
    Staczek J, Steplewski Z, Weinmann R, Klein G, Koprowski H.
    J Cell Physiol; 1981 Jun 01; 107(3):391-8. PubMed ID: 6265479
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K, Suzumiya J, Tasiro K, Mukai Y, Tanaka T, Kato A, Kikuchi M.
    Am J Hematol; 1996 May 01; 52(1):21-8. PubMed ID: 8638607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.